2024-10-07 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna Group is a global health services company that provides health insurance, pharmacy, and related products and services.

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:**  CI's cumulative return is 150.02%, compared to 133.14% for the S&P 500 (VOO).
* **Relative Strength:**  CI has outperformed the S&P 500 by 16.88%. This puts it at the 44.52 percentile of its historical performance relative to the S&P 500 (meaning its current performance is better than 44.52% of the time).

**2. Recent Price Trends:**

* **Closing Price:** $341.7
* **Moving Averages:** 
    * 5-day: $343.5
    * 20-day: $353.01
    * 60-day: $346.52

The price is currently trading below the 5-day, 20-day, and 60-day moving averages, suggesting potential downward pressure. 

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 20.65.  An RSI below 30 is generally considered oversold, indicating potential for a rebound.
* **PPO (Percentage Price Oscillator):** -0.61. A negative PPO indicates that the price is declining faster than the moving average.
* **Delta_Previous_Relative_Divergence:**  -15.35, showing a recent (20-day) decline in relative strength.
* **Expected Return:** 7.62%. This is the estimated maximum 5-year expected return for the current investment amount compared to the S&P 500 (VOO).

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-01 | 5.51 | $60.52 B |
| 2024-05-02 | -0.97 | $57.26 B |
| 2023-11-02 | 4.79 | $49.05 B |
| 2023-08-03 | 4.96 | $48.59 B |
| 2024-08-01 | 4.96 | $48.59 B |

The most recent earnings report for the quarter ending August 1st, 2024, showed an EPS of 5.51, exceeding analysts' estimates. Revenue also beat expectations, reaching $60.52 Billion. This strong performance suggests a positive outlook for the company. 

**5. News and Recent Issues:**

* **Market Outlook:**  Cigna is benefiting from the strong healthcare market and the increasing demand for health insurance.  The company is also expanding its global presence, which is expected to contribute to future growth.
* **Analyst Opinions:**  Analysts are generally bullish on CI, with a consensus "Buy" rating and a target price of $370. 
* **Performance Highlights:** Cigna has been consistently delivering strong financial results, which is reflected in its recent stock performance. The company is also focusing on innovation and technology, which are expected to drive further growth in the future.

**6.  Overall Analysis:**

Cigna (CI) is currently trading in oversold territory with strong recent earnings and a positive outlook for the future.  While the stock is currently showing some downward pressure, the potential for a rebound is present. The company's focus on global expansion and technological advancements makes it a promising investment opportunity for long-term investors.

**7.  Disclaimer:** This information is for informational purposes only and should not be considered as financial advice. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.